Literature DB >> 7258825

The role of immune complexes in the pathogenesis of pleural effusions.

B S Andrews, N S Arora, M F Shadforth, S K Goldberg, J S Davis.   

Abstract

Thirty-two patients with pleural effusions (7 malignant, 5 with connective tissue disease, 5 with infections, 9 idiopathic, 6 miscellaneous) were studied to determine if immune complex formation might be involved in the pathogenesis of pleural fluid formation. Immune complexes were detected in serum, pleural fluid and in parietal pleural capillaries using direct immunofluorescence in the following groups: malignant disease (57%, 29%, 67%), connective tissue diseases (100%, 100%, 100%), infectious diseases (0%, 44%, 67%), idiopathic (67%, 44%, 75%), and miscellaneous (25%, 17%, 0%). Whereas the degree of immune complex was higher in serum than in pleural fluid in patients with malignant disease, the converse was true in patients with connective tissue diseases. Activation of C3 and properdin factor B was almost invariable in pleural fluid from patients with connective tissue disease and bacterial infections. These data suggested that pleural immune complexes are frequently associated with exudative pleural effusions. Immune complexes may lead to formation of pleural fluid by increasing capillary permeability. This may result from either a local Arthus-type reaction within the pleura, local immune complex formation within pleural fluid leading to release of inflammatory mediators, and/or deposition of circulating immune complexes in pleural vessels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7258825     DOI: 10.1164/arrd.1981.124.2.115

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  4 in total

1.  Refractory massive pleural effusion in systemic lupus erythematosus treated with talc poudrage.

Authors:  J L Kaine
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

Review 2.  Video assisted thoracoscopic and open chest surgery in diagnosis and treatment of malignant pleural diseases.

Authors:  Periklis Perikleous; David A Waller
Journal:  J Vis Surg       Date:  2017-06-22

3.  Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion.

Authors:  Kuan-Yuan Chen; Po-Hao Feng; Chih-Cheng Chang; Tzu-Tao Chen; Hsiao-Chi Chuang; Chun-Nin Lee; Chien-Ling Su; Lian-Yu Lin; Kang-Yun Lee
Journal:  Int J Gen Med       Date:  2016-06-11

4.  Assessing the Function of the ZFP90 Variant rs1170426 in SLE and the Association Between SLE Drug Target and Susceptibility Genes.

Authors:  Tingting Zhu; Yuandi Huang; Danfeng Qian; Yuming Sheng; Chaowen Zhang; Shirui Chen; Hui Zhang; Hui Wang; Xuejun Zhang; Junlin Liu; Changhai Ding; Lu Liu
Journal:  Front Immunol       Date:  2021-03-16       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.